As the pre-eminent event on the Chinese pharmaceutical market, Impact China IV provides the most vital and progressive sessions lead by the foremost experts in the industry.

For 2008, Impact China has been elevated to its most senior level yet. As the Chinese market continues to mature, now is the time to fully develop a decisive stratagem for accessing the market and realize the benefits that China offers.

Over the past four years, the Impact China series has attracted hundreds of the world's leading pharmaceutical and biotech executives.

A few of the hottest topics for the event include:

- Examinations of the Chinese Market: Economic Outlook, China's expanding appetite for pharmaceuticals and continued march on to the global scene;

- Chinese Market Challenges: infrastructure; chemical manufacturers; counterfeit drugs; quality control; environmental concerns; quality of standards

- Building effective partnerships between East and West: Options in sharing risk and reward

- Developed strategies to access the rapidly growing CRO market to meet your outsourcing goals and budgets

- Can the exponential maturation of the CRO market continue? Are CROs capable of meeting Western benchmarks and objectives?

- Ensuring GLP and GMP protocol in an unregulated market

- Protecting your Intellectual Property and Patent Laws; and Understanding the laws and working with the Chinese Government to guarantee your products safety

- Changes to the taxation policies and the impact on the benefits of outsourcing